Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Linus Health has developed an AI-powered digital platform for early detection of cognitive impairment. Its DCTclock™ tool—an iPad-based version of the Clock Drawing Test—has demonstrated enhanced sensitivity over traditional methods. The company’s solutions are used in clinical settings to screen for early signs of dementia and guide personalized interventions. Recent acquisitions have expanded its capabilities into speech analytics and physical function assessment. Clinical results highlight improved detection rates compared to legacy pen-and-paper assessments.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Linus Health.